Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| BetterHelp | UNKNOWN |
Not provided
Not provided
Not provided
A digital mental health intervention (BetterHelp, Mountain View, CA) provides users with access to online therapy care for treatment of depression and anxiety. This feasibility randomized controlled trial compares clinical outcomes of an intervention group, who will enroll in the digital mental health platform, to a control group.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Participants enrolled in a digital mental health platform, which provided access to licensed therapists, group therapy sessions, and a library of educational articles. |
|
| Control | No Intervention | Participants were not enrolled in a digital mental health platform, but continued their standard routine or care as needed. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BetterHelp | Other | Use program as needed for 16 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment | Recruitment rates for study participation | 90 days |
| Adherence | Adherence rates to study procedures | 90 days |
| Measure | Description | Time Frame |
|---|---|---|
| GAD-7 | Anxiety will be measured by the Generalized Anxiety Disorder Scale (GAD-7), ranging from 0 (no anxiety) to 21 (severe anxiety). The percentage of participants who achieved a minimal clinically important difference (MCID) of 4 points or more will also be reported for each group, as based on literature. | Baseline, 45 days, 90 days |
| Measure | Description | Time Frame |
|---|---|---|
| Workplace Productivity | Workplace productivity will be measured by the Work Productivity and Activity Impairment Questionnaire (WPAI) and reported for both groups. | Baseline, 45 days, 90 days |
| Sleep | Sleep quality will be measured by the Jenkins Sleep Scale (JSS-4) and reported for both groups. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mindy Hong, PhD | Contact | 615-498-8308 | mindy.hong@teladochealth.com | |
| Mona Barman, PhD | Contact | mona.barman@teladochealth.com |
| Name | Affiliation | Role |
|---|---|---|
| Mindy Hong, PhD | Teladoc Health | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| PHQ-9 |
Depression will be measured by the Patient Health Questionnaire (PHQ-9), ranging from 0 (no depression) to 27 (severe depression). The percentage of participants who achieved a minimal clinically important difference (MCID) of 5 points or more will also be reported for each group, as based on literature. |
| Baseline, 45 days, 90 days |
| Baseline, 45 days, 90 days |
| Stress | Stress levels will be measured by the Perceived Stress Scale (PSS-10) and reported for both groups. | Baseline, 45 days, 90 days |